Your browser doesn't support javascript.
loading
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
Colagrossi, Luna; Hermans, Lucas E; Salpini, Romina; Di Carlo, Domenico; Pas, Suzan D; Alvarez, Marta; Ben-Ari, Ziv; Boland, Greet; Bruzzone, Bianca; Coppola, Nicola; Seguin-Devaux, Carole; Dyda, Tomasz; Garcia, Federico; Kaiser, Rolf; Köse, Sukran; Krarup, Henrik; Lazarevic, Ivana; Lunar, Maja M; Maylin, Sarah; Micheli, Valeria; Mor, Orna; Paraschiv, Simona; Paraskevis, Dimitros; Poljak, Mario; Puchhammer-Stöckl, Elisabeth; Simon, François; Stanojevic, Maja; Stene-Johansen, Kathrine; Tihic, Nijaz; Trimoulet, Pascale; Verheyen, Jens; Vince, Adriana; Lepej, Snjezana Zidovec; Weis, Nina; Yalcinkaya, Tülay; Boucher, Charles A B; Wensing, Annemarie M J; Perno, Carlo F; Svicher, Valentina.
Afiliación
  • Colagrossi L; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
  • Hermans LE; Virology, Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Salpini R; Department of Viroscience, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Di Carlo D; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
  • Pas SD; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.
  • Alvarez M; Department of Viroscience, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Ben-Ari Z; Servicio de Microbiología, Hospital San Cecilio, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada, Granada, Spain.
  • Boland G; Liver Disease Centre, Sheba Medical Centre, Ramat Gan, Israel.
  • Bruzzone B; Virology, Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Coppola N; Hygiene Unit, IRCCS AOU San Martino - IST, Genoa, Italy.
  • Seguin-Devaux C; Malattie Infettive, Seconda Università degli studi di Napoli, Naples, Italy.
  • Dyda T; Laboratory of Retrovirology, CRP-Santé, Luxembourg, Luxembourg.
  • Garcia F; Molecular Diagnostics Laboratory, Hospital of Infectious Diseases, Warsaw, Poland.
  • Kaiser R; Servicio de Microbiología, Hospital San Cecilio, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada, Granada, Spain.
  • Köse S; Institute of Virology, University of Cologne, Cologne, Germany.
  • Krarup H; Izmir Tepecik Education and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, Izmir, Turkey.
  • Lazarevic I; Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
  • Lunar MM; Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Maylin S; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Micheli V; Service de Microbiologie, University Paris Diderot, Hôpital Saint Louis, Paris, France.
  • Mor O; L. Sacco Hospital, Milan, Italy.
  • Paraschiv S; National HIV Reference Laboratory, Central Virology Laboratory, Ministry of Health, Tel Hashomer, Ramat Gan, Israel.
  • Paraskevis D; Molecular Diagnostics Laboratory, National Institute for Infectious Diseases "Matei Bals", Bucharest, Romania.
  • Poljak M; National Retrovirus Reference Centre, Department of Hygiene, Epidemiology and Medical Statistics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Puchhammer-Stöckl E; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Simon F; Department for Virology, Medical University of Vienna, Vienna, Austria.
  • Stanojevic M; Service de Microbiologie, University Paris Diderot, Hôpital Saint Louis, Paris, France.
  • Stene-Johansen K; Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Tihic N; Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
  • Trimoulet P; Institute of Microbiology, Polyclinic for Laboratory Diagnostics, University Clinical Centre Tuzla, Tuzla, Bosnia and Herzegovina.
  • Verheyen J; Virology Laboratory, Centre Hospitalier Régional et Université "Victor Segalen", Bordeaux, France.
  • Vince A; Institute of Virology, University-Hospital, University Duisburg-Essen, Essen, Germany.
  • Lepej SZ; University of Zagreb School of Medicine and University Hospital for Infectious Diseases, Zagreb, Croatia.
  • Weis N; University of Zagreb School of Medicine and University Hospital for Infectious Diseases, Zagreb, Croatia.
  • Yalcinkaya T; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.
  • Boucher CAB; Refik Saydam National Public Health Agency, Ankara, Turkey.
  • Wensing AMJ; Department of Viroscience, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • Perno CF; Virology, Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Svicher V; Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy. cf.perno@uniroma2.it.
BMC Infect Dis ; 18(1): 251, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29859062

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Virus de la Hepatitis B / Codón de Terminación / Hepatitis B Crónica / Antígenos de Superficie de la Hepatitis B / Mutación Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Virus de la Hepatitis B / Codón de Terminación / Hepatitis B Crónica / Antígenos de Superficie de la Hepatitis B / Mutación Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2018 Tipo del documento: Article País de afiliación: Italia